ANTHEM

Anthem Biosciences vs Peers

₹885.95-0.49%
Market cap
₹49,765 crore
P/E
86.4
P/B
16.36
ROE
21.7%
Dividend yield
0.23%

Anthem Biosciences ranks 19th by market capitalisation among 105 Healthcare companies tracked by ATS. Its largest peers are Sun Pharmaceutical Industries, Divi's Laboratories and Torrent Pharmaceuticals. Its P/E of 86.4 compares with a peer median of 42.8.

Anthem Biosciences vs Healthcare peers

Sorted by market capitalisation.

Anthem Biosciences and peers compared on size, valuation and returns
CompanyClose (₹)1DMarket cap (₹ cr)P/EP/BROE1Y return
Sun Pharmaceutical Industries1,773.60-1.69%4,25,54635.25.0914.7%+12.5%
Divi's Laboratories9,586.00+0.38%2,54,47887.015.1816.2%+12.5%
Torrent Pharmaceuticals4,693.90-1.64%1,58,86372.818.9427.1%+12.5%
Zydus Lifesciences1,151.30-0.71%1,15,84825.74.2719.7%+12.5%
Apollo Hospitals Enterprise7,884.00-0.39%1,13,36054.311.9622.0%+12.5%
Laurus Labs2,052.90+0.14%1,10,827101.420.9118.2%+12.5%
Cipla1,333.00-0.54%1,07,67732.03.1311.8%+12.5%
Mankind Pharma2,496.00-0.16%1,03,04250.46.3212.5%+12.5%
Dr. Reddy's Laboratories1,194.90-1.08%99,53330.12.6012.1%+12.5%
Aurobindo Pharma1,677.90-0.88%97,45326.32.579.9%+12.5%
Anthem Biosciences885.95-0.49%49,76586.416.3621.7%+22.0%

Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.

Anthem Biosciences peer comparison — frequently asked questions

Who are Anthem Biosciences' competitors?

Anthem Biosciences' listed peers in Healthcare include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Apollo Hospitals Enterprise and Laurus Labs, ranked here by market capitalisation.

How does Anthem Biosciences' P/E compare with its peers?

Anthem Biosciences trades at a P/E of 86.4, against a median of 42.8 across the 10 Healthcare peers shown.

Which is the largest company among Anthem Biosciences' peers?

By market capitalisation, the largest company in the group is Sun Pharmaceutical Industries at ₹4.26 lakh crore, against ₹49,765 crore for Anthem Biosciences.

Same Data For Peers

Trade Anthem Biosciences With ATS

Track ANTHEM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.